Related references
Note: Only part of the references are listed.Fifty years with aspirin and platelets
Carlo Patrono
BRITISH JOURNAL OF PHARMACOLOGY (2023)
Cyclooxygenase Inhibitors and Cancer: The Missing Pieces
Carlo Patrono
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2023)
Urinary Thromboxane B2 and Lethal Prostate Cancer in African American Men
Maeve Kiely et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2022)
The role of P-selectin in cancer-associated thrombosis and beyond
Eilam Yeini et al.
THROMBOSIS RESEARCH (2022)
Inflammation and Cancer: From the Development of Personalized Indicators to Novel Therapeutic Strategies
Patrizia Ballerini et al.
FRONTIERS IN PHARMACOLOGY (2022)
Aspirin and the USPSTF-What About Cancer?
Andrew T. Chan
JAMA ONCOLOGY (2022)
Hemostasis and cancer: Impact of haemostatic biomarkers for the prediction of clinical outcomes in patients with cancer
Florian Moik et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)
The Role and Regulation of Thromboxane A2 Signaling in Cancer-Trojan Horses and Misdirection
Anthony W. Ashton et al.
MOLECULES (2022)
The specific deletion of cyclooxygenase-1 in megakaryocytes/platelets reduces intestinal polyposis in ApcMin/+ mice
Annalisa Bruno et al.
PHARMACOLOGICAL RESEARCH (2022)
Association of Thromboxane Generation With Survival in Aspirin Users and Nonusers
Jeffrey J. Rade et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Incidence of Cancer Among Adults With Thrombocytosis in Ontario, Canada
Vasily Giannakeas et al.
JAMA NETWORK OPEN (2021)
Aspirin and the risk of colorectal and other digestive tract cancers: an updated meta-analysis through 2019
C. Bosetti et al.
ANNALS OF ONCOLOGY (2020)
Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality
Tracey G. Simon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Cancer incidence following a high-nor a platelet count: cohort study using electronic healthcare records from English primary care
Luke T. A. Mounce et al.
BRITISH JOURNAL OF GENERAL PRACTICE (2020)
Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial
John Burn et al.
LANCET (2020)
Platelets and Metastasis: New Implications of an Old Interplay
Serena Lucotti et al.
FRONTIERS IN ONCOLOGY (2020)
Mechanisms of Colorectal Cancer Prevention by Aspirin-A Literature Review and Perspective on the Role of COX-Dependent and -Independent Pathways
Ranjini Sankaranarayanan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The effect of smoking on chronic inflammation, immune function and blood cell composition
Ingrid Elisia et al.
SCIENTIFIC REPORTS (2020)
Aspirin blocks formation of metastatic intravascular niches by inhibiting platelet-derived COX-1/thromboxane A2
Serena Lucotti et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
The History of Armand Trousseau and Cancer-Associated Thrombosis
Pat Metharom et al.
CANCERS (2019)
Obesity is associated with impaired responsiveness to once-daily low-dose aspirin and in vivo platelet activation
Giovanna Petrucci et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Platelets, Thrombo-Inflammation, and Cancer: Collaborating With the Enemy
Ana Luisa Palacios-Acedo et al.
FRONTIERS IN IMMUNOLOGY (2019)
Measurement of Thromboxane Biosynthesis in Health and Disease
Carlo Patrono et al.
FRONTIERS IN PHARMACOLOGY (2019)
Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial
Nalinie Joharatnam-Hogan et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
Motivation for Launching a Cancer Metastasis Inhibition (CMI) Program
Jill M. Pulley et al.
TARGETED ONCOLOGY (2018)
Aspirin, platelet inhibition and cancer prevention
Paola Patrignani et al.
PLATELETS (2018)
Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus
Louise Bowman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Role of platelets and platelet receptors in cancer metastasis
Martin Schlesinger
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Oxidant stress as a major determinant of platelet activation in invasive breast cancer
Patrizia Ferroni et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Cancer-associated venous thromboembolism: Burden, mechanisms, and management
Cihan Ay et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Clinical relevance of thrombocytosis in primary care: a prospective cohort study of cancer incidence using English electronic medical records and cancer registry data
Sarah E. R. Bailey et al.
BRITISH JOURNAL OF GENERAL PRACTICE (2017)
Low-Dose Aspirin Acetylates Cyclooxygenase-1 in Human Colorectal Mucosa: Implications for the Chemoprevention of Colorectal Cancer
P. Patrignani et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Platelet count as a predictor of metastasis and venous thromboembolism in patients with cancer
Joanna L. Sylman et al.
CONVERGENT SCIENCE PHYSICAL ONCOLOGY (2017)
Effect of low-dose aspirin use on survival of patients with gastrointestinal malignancies; an observational study
M. A. Frouws et al.
BRITISH JOURNAL OF CANCER (2017)
In Vivo Platelet Activation and Aspirin Responsiveness in Type 1 Diabetes
Francesco Zaccardi et al.
DIABETES (2016)
Association of platelet activation markers with cancer-associated venous thromboembolism
Julia Riedl et al.
PLATELETS (2016)
ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours
Christopher Coyle et al.
CONTEMPORARY CLINICAL TRIALS (2016)
Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells
Paloma Guillem-Llobat et al.
ONCOTARGET (2016)
Aspirin and colorectal cancer: the promise of precision chemoprevention
David A. Drew et al.
NATURE REVIEWS CANCER (2016)
Platelets at the interface of thrombosis, inflammation, and cancer
Aime T. Franco et al.
BLOOD (2015)
Estimates of benefits and harms of prophylactic use of aspirin in the general population
J. Cuzick et al.
ANNALS OF ONCOLOGY (2015)
Stability of Urinary Thromboxane A2 Metabolites and Adaptation of the Extraction Method to Small Urine Volume
Francesca Pagliaccia et al.
CLINICAL LABORATORY (2014)
Reappraisal of the clinical pharmacology of low-dose aspirin by comparing novel direct and traditional indirect biomarkers of drug action
P. Patrignani et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Effect of assay specificity on the association of urine 11-dehydro thromboxane B2 determination with cardiovascular risk
M. T. Olson et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
The role of aspirin in cancer prevention
Michael J. Thun et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
Peter M. Rothwell et al.
LANCET (2011)
The role of COX-2 in intestinal inflammation and colorectal cancer
D. Wang et al.
ONCOGENE (2010)
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays Implications for Aspirin Resistance
Francesca Santilli et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Determinants of platelet activation in Alzheimer's disease
Giovanni Ciabattoni et al.
NEUROBIOLOGY OF AGING (2007)
Efficacy and safety of low-dose aspirin in polycythemia vera
R Landolfi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Platelet activation in obese women -: Role of inflammation and oxidant stress
G Davì et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Share Paper
